Medication reference
Ticarcillin-clavulanate
Monograph awaiting updateThis monograph will be updated in the future.
Historical source. Current clinical review is incomplete. This monograph will be updated in the future.
Ticarcillin /Clavulonic acid -Timentin® (opens in a new tab)Original source URL: https://globalrph.com/dilution/ticarcillin-clavulonic-acid-timentin/ | Retrieved 2026-11-04
Source dates, location and integrity
This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.
- Original source URL
- https://globalrph.com/dilution/ticarcillin-clavulonic-acid-timentin/ (opens in a new tab)
- Source date
- Not established in the retrieved source
- Retrieved
- 2026-11-04T19:50:05.126528+00:00
- Source location
- div.post-content
- Packaged content SHA-256
- eb7dbfe7052bff1ad3b659834155c40399838540996dfb17c0ff7b8da325515c
- Original response SHA-256
- 8462f98c5d7ce54903a41eca1550c6db80550410a83ed507d84a70d23fe4a76c
- Source body SHA-256
- 514e88d6fc0a6fe3e53a1468717f11e1271f1b7d8fea21ba11a21136e18d3f09
Ticarcillin / Clavulonic acid ( Timentin ®) |
| The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. |
Usual Diluents |
| NS, D5W |
Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate] |
| [0 to 2.5 grams] [50 ml] [30 min]
[Over 2.5 grams] [100ml] [30 min] |
Stability / Miscellaneous |
| EXP: 1 DAY room temperature or 3 DAYS if refrigerated. Label: Refrigerate. Cannot be given IM.Usual dose: 3.1g IVPB q4-6h. |
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- adjustment_required
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- class_level
- Provenance classification
- historical_class_level
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- ticarcillin-clavulanate
Source ID
H51-0CE7358F81CC1AD404D429E5 - Generic name
- Ticarcillin-clavulanate
Source ID
H51-70F424BDE4D24A224A41EF8C - Class
- Antibacterial
Source ID
H51-310C979C74C90E97111FD904 - Subclass
- Legacy GlobalRPh directory entry
Source ID
H51-94EA6D565282C4A6712A2011 - Primary uses
- Selected susceptible bacterial infections; indication, site, organism, local susceptibility, and current labeling determine use.
Source ID
H51-A19D70DE8BBE9AA1F68C3D43
- Selected susceptible bacterial infections; indication, site, organism, local susceptibility, and current labeling determine use.
- Mechanism
- Beta-lactam binding to bacterial penicillin-binding proteins inhibits peptidoglycan cross-linking and cell-wall synthesis.
Source ID
H51-347913BBEEE703A2E8B0280E - Mechanism level
- class_level
Source ID
H51-3CBE34884E18CD013BDEE3D5 - Basic dosing orientation
- The existing GlobalRPh dose and preparation quick reference loads automatically below. Treat it as historical continuity, then confirm the exact current DailyMed label, population, indication, renal function, and institutional policy.
Source ID
H51-9986AE81F90766BD36A6BC1C - Administration orientation
- Route, dilution, concentration, and administration details load automatically from the existing GlobalRPh quick reference below; current exact-product verification remains required.
Source ID
H51-7A95C3F93FDFE2F8E04F421B - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method.
Source ID
H51-8C69423B16F71FFF652AC53D - Key safety orientation
- Legacy content must be reconciled against current labeling and institutional policy before clinical use.
Source ID
H51-9CD909427E1FD602903BF8F7
- Legacy content must be reconciled against current labeling and institutional policy before clinical use.
- Coverage path
- automatic_legacy_quick_reference
Source ID
H51-57F50DAA2468EAF3D8721315 - Coverage path label
- Automatic legacy GlobalRPh quick reference
Source ID
H51-6E346F62834A7496588E4218 - Legacy title
- Ticarcillin-clavulanate
Source ID
H51-9E452E244876EE1C90730BB6 - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-6187F552EF439E167164FAB4 - Search text
- Ticarcillin-clavulanate Antibacterial Legacy GlobalRPh directory entry Selected susceptible bacterial infections; indication, site, organism, local susceptibility, and current labeling determine use. Beta-lactam binding to bacterial penicillin-binding proteins inhibits peptidoglycan cross-linking and cell-wall synthesis. The existing GlobalRPh dose and preparation quick reference loads automatically below. Treat it as historical continuity, then confirm the exact current DailyMed label, population, indication, renal function, and institutional policy. Route, dilution, concentration, and administration details load automatically from the existing GlobalRPh quick reference below; current exact-product verification remains required. Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method. Legacy content must be reconciled against current labeling and institutional policy before clinical use. Automatic legacy GlobalRPh quick reference
Source ID
H51-8A0605C912D96817F411F2F3 - Official search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Ticarcillin-clavulanate (opens in a new tab)
Source ID
H51-4EA2FA6FBDB4350FFC8CBC3E - Official access mode
- search
Source ID
H51-97E1E831D720E22D5815A076 - Official access url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Ticarcillin-clavulanate (opens in a new tab)
Source ID
H51-3F663EDD520731E50F885F9B - Official search query
- Ticarcillin-clavulanate
Source ID
H51-1216751BD861035EB1064842 - Official access reason
- A source-backed DailyMed search is available; select and confirm the exact IV product.
Source ID
H51-A8A69FCFA2C6078BFED090E0
No separate structured rows were bundled for preparation, IV push, continuous infusion, population dosing, dialysis, CRRT. Historical article content and source links may cover these topics.
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- adjustment_required
Source ID
H51-48B6066FFD914D7897DB5AC1 - Summary
- Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method.
Source ID
H51-E0B4966A7E11C55D69066118 - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-FC3011E7E75591A90F9C2ACF
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
- Legacy content must be reconciled against current labeling and institutional policy before clinical use.
Source ID
H51-9E20CB35EA41B605B92C5CAB
Historical Stability notes
Recovered v5.1 source content; historical, awaiting current review.
- Legacy product stability information is not automatically equivalent to a USP <797> BUD.
Source ID
H51-84717314840BE9B6B5024C4A
Historical supplemental professional sources
Recovered v5.1 source content; historical, awaiting current review.
| Label | Url | Kind |
|---|---|---|
Source IDH51-80CFDEA872ADD221535AF4FCSource IDH51-C2552D02F306E036E2633958 | https://idmp.ucsf.edu/adult-antimicrobial-dosing-non-dialysis (opens in a new tab)Source IDH51-1F27A14A2486A675BA8924A8 | Professional institutional guidanceSource IDH51-F727C5239DB0CEA5E510832C |
Source IDH51-D36B0ACCD0F97DFA46FA8022Source IDH51-4F0207CDAE38D4B267B124B2 | https://idmp.ucsf.edu/antimicrobial-dosing-intermittent-continuous-hemodialysis (opens in a new tab)Source IDH51-1BE192FBF911CECA0A6D692E | Professional institutional guidanceSource IDH51-0A23A5241444BA50315EE7C8 |
Source IDH51-D4AE976D20074774246307C5Source IDH51-B827B7F3DB96E4D0F17763E5 | https://idmp.ucsf.edu/pediatric-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)Source IDH51-73CBC5D68E13C9A7752E359E | Professional institutional guidanceSource IDH51-15C978364427040D478089D1 |
Source IDH51-6E2704F6B746D4F80A9460F7Source IDH51-687F184E88EA7D934BD9CEEF | https://idmp.ucsf.edu/neonatal-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)Source IDH51-3E35402727CB5FC605A8670A | Professional institutional guidanceSource IDH51-C988F560642AE97189E4D410 |
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
ticarcillin-clavulanateSource ID
H51-1F28120FA296A2B548694BF5Legacy title
Ticarcillin-clavulanateSource ID
H51-6FC724E9939F32A75C70C3E6Generic name
Ticarcillin-clavulanateSource ID
H51-FB94B0F30236E0FA31EB0381Class
AntibacterialSource ID
H51-E5FA197996EA49A5D561FAC7Subclass
Legacy GlobalRPh directory entrySource ID
H51-1E5862CC19B922848BF03A5ASummary
Existing GlobalRPh IV dilution monograph retained for migration into the unified reference.Source ID
H51-8B27F3B9EEB6D27FDA9F4444Populations
- Population not yet normalized
Source ID
H51-576788D25EAFA981754E60C0
Evidence tier
Legacy catalog - migration review requiredSource ID
H51-C25E611EE68796C8AEB6C4DAHigh alert
falseSource ID
H51-DA9E609F9DD25AE3D34188C2Hazardous
falseSource ID
H51-7DCC9A6AC7B249683F8CA034Status
Legacy migrationSource ID
H51-CB2EC4FF24FCD8297CE426F0Version added
LegacySource ID
H51-1D7C90605722A35E08BEE37CSources
| Label | Url | Kind |
|---|---|---|
Source IDH51-E2E8507C9D0ED42D158B32B0Source IDH51-DA530E162A9828941F289240 | legacy:autoSource IDH51-DE7663E352F44322EC3F1983 | LegacySource IDH51-F2C63AFF97A5675BA1FCD5C6 |
Clinical release verification
- Audit version
- 3.4
Source ID
H51-6B74F11B0712A96C9EE84CFC - Audited on
- 2026-08-30
Source ID
H51-123211166B0B3B0D5D814816 - Level
- amber
Source ID
H51-53D9BFC34D1E8369D7AAC4CA - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-55DF32F4F5CCB14B8A2BAC2C - Exact current label candidate
- false
Source ID
H51-2D9D466F0C9992596D5E0839 - Reference url count
- 4
Source ID
H51-FF953787D59B8B23C17B3A03 - Broken reference count
- 0
Source ID
H51-DA253502DAD7852E91E49C8D - Point of use confirmation required
- true
Source ID
H51-08C35974A147A8C19F04AEED - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-1D4B6B33A262CAC7C366357B - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ticarcillin-clavulanate (opens in a new tab)
Source ID
H51-6F458732CEEBBFEDC1F0919D
Dosing source fields
Id
ticarcillin-clavulanateSource ID
H51-AB0B8FF38820239F414E463EGeneric name
Ticarcillin-clavulanateSource ID
H51-F8ADF848D016AEA8B96137BFCoverage status
direct_official_label_access_plus_legacy_referenceSource ID
H51-F0AC3EA5ADBB58E4CA7C9DC4Package insert
- Query name
- Ticarcillin-clavulanate
Source ID
H51-2A4E5D80AE9921F17EE6E3A6 - Product and route must match
- true
Source ID
H51-94A5031FF77E962B0E0D641E - Live current label enabled
- false
Source ID
H51-D548112E06D147F5FA38EB57 - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-8E5AA0D489DE3304A0C6FC78 - Direct official label access enabled
- true
Source ID
H51-B0F137936E6126C4D1083D1C - Outbound server request required
- false
Source ID
H51-E8E26CE59330D3382244C7BE - Local summary status
- not_bundled
Source ID
H51-E3AEA12A7DA1136F95A42F72
Clinical review
- Locally normalized
- false
Source ID
H51-CDC5E2F249F4A75FEE48E479 - Reviewed
- 2026-08-29
Source ID
H51-17442425B26BCF795BB276D7 - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-D567C09EE606EC3C1B89409B
Clinical release verification
- Audit version
- 3.4
Source ID
H51-75759A3774B62CDCDFD34CB6 - Audited on
- 2026-08-30
Source ID
H51-3E8C5DE769888AAA7BFAF8EB - Level
- amber
Source ID
H51-956CB2109748A30D681116DA - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-955699410A3FE79924339B97 - Exact current label candidate
- false
Source ID
H51-1EEF41176D5B1CE2587DE479 - Reference url count
- 4
Source ID
H51-F65E906278FD5A8A76FE5266 - Broken reference count
- 0
Source ID
H51-1AD405A2E60FACDC7884AA02 - Point of use confirmation required
- true
Source ID
H51-50EA0A2A9B69FCC1A7FF11A6 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-93C66717FA010F36C0EE107E - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ticarcillin-clavulanate (opens in a new tab)
Source ID
H51-25B77603ED43EF6800500F68
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- ticarcillin-clavulanate
Source ID
H51-CAB4848D652FDD31F093DA8A - Name
- Ticarcillin-clavulanate
Source ID
H51-9AC42E683E0E883792D7EC96 - Therapeutic class
- Antibacterial
Source ID
H51-A46101A49719123BFEBCAC4E - Review version
- 3.1
Source ID
H51-3C50CC6B6956F213D0C311D1 - Review date
- 2026-08-30
Source ID
H51-2CB0B73EEF0EBFD9D57066C4 - Release status
- no_released_dilution_current_label_review_required
Source ID
H51-E89B7630AE8757D5BC7467D7 - Market status
- Status
- no_current_us_iv_spl_confirmed
Source ID
H51-0EDC594099942CB397F99F7B - Basis
- No high-confidence current IV SPL was automatically selected; legacy information is segregated
Source ID
H51-B1F430FA1C46FB5CF5DA974A
- Ten point assessment
- Exact formulation
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-957F337252BAB613B2E96F2B - Reconstitution concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-F301A2B3DA882FAA802BAF48 - Maximum or recommended final concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-C039839C8CBE720118CB2081 - Appropriate standardized containers
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-ACE119A3C2300BD99E1F1A76 - Adult dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-E9E079E7BBBD8CFC23A58A37 - Pediatric dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-2D5E2E1150616295F4A29676 - Neonatal dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-B39FF5EC09E28E3DC704197F - Infusion time
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-3C1BDCECBCAFF243A3AD2046 - Fluid restriction alternatives
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-8EAB7581A5717FCB88E11FFD - Current manufacturer labeling
- Match confidence
- unresolved
Source ID
H51-BB3E3873F8D38683B6323357 - Url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ticarcillin-clavulanate (opens in a new tab)
Source ID
H51-90D8B2F8E553905FF873D9A8
- Field provenance
- Exact formulation
- Primary
- not_found
Source ID
H51-B3E5A13765FF30B405EDB203
- Reconstitution concentration
- Primary
- not_found
Source ID
H51-03F7B22452811F409850C3FA
- Maximum or recommended final concentration
- Primary
- not_found
Source ID
H51-2F100AAE8EEDF3C91CF52931
- Appropriate standardized containers
- Primary
- not_found
Source ID
H51-E6F581D2243154F42F6EA8A1
- Adult dosing range
- Primary
- not_found
Source ID
H51-F4F068CF498F213C7325DD77
- Pediatric dosing range
- Primary
- not_found
Source ID
H51-BD2E06B0C89BD075A5306784
- Neonatal dosing range
- Primary
- not_found
Source ID
H51-4B45FD488A4666F4E568E551
- Infusion time
- Primary
- not_found
Source ID
H51-75245B72E546850B06A7B5C8
- Fluid restriction alternatives
- Primary
- not_found
Source ID
H51-B68FA4134166DA225F9117D6
- Current manufacturer labeling
- Primary
- DailyMed search gateway
Source ID
H51-7DCA5D876109A8EED3D01FF3
- Population applicability
- Adult
- Applicability
- not_established
Source ID
H51-6D13E4FD2E26F8A8817B469B - Guide generation allowed
- false
Source ID
H51-6D34BCD4FCCF08CEA61AEEF0
- Pediatric
- Applicability
- supported_or_source_present
Source ID
H51-E932CAF270B7E7255427BD13 - Guide generation allowed
- false
Source ID
H51-E9EF5EFE96856F14CE5639A5
- Neonatal
- Applicability
- supported_or_source_present
Source ID
H51-E286A879A34C0A8B4A6AFBC1 - Guide generation allowed
- false
Source ID
H51-4C8E31147097BA0B65FCAF4A
- Route presence
- Structured dilution
- false
Source ID
H51-3FABC158E3786D1658CA32D3 - Iv push
- false
Source ID
H51-F371713903FBB4B4A90F9749 - Continuous infusion
- false
Source ID
H51-56AB29F5C36D2FF16C9FDDCB - Pediatric source
- true
Source ID
H51-BF755C62AC27FF12B6CF6CC5 - Neonatal source
- true
Source ID
H51-2AA29F0FC4BCD4BBF046D1B4
- Legacy reference
- Status
- not_available
Source ID
H51-37B075A3F724B70CA81D70B8
- Label resolution
- Status
- build_environment_network_unavailable
Source ID
H51-E3EF27A516DB903F79D6809A
- Source files
- catalog.json
Source ID
H51-88A00CD757E36727BB876267 - dosing.json
Source ID
H51-E9AF760F6139E12436D5C23B - legacy-map.json
Source ID
H51-BB59E469ECDD569AE4CA1C4F - review-queue.json
Source ID
H51-6659AD47CDBB7E23F27B2FC9
- catalog.json
- Clinical release note
- Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
Source ID
H51-D0A63380C8C041C955999C89
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-1F28120FA296A2B548694BF5 | catalog.json/records/238/id | Historical; current review incomplete |
H51-6FC724E9939F32A75C70C3E6 | catalog.json/records/238/legacy_title | Historical; current review incomplete |
H51-FB94B0F30236E0FA31EB0381 | catalog.json/records/238/generic_name | Historical; current review incomplete |
H51-E5FA197996EA49A5D561FAC7 | catalog.json/records/238/class | Historical; current review incomplete |
H51-1E5862CC19B922848BF03A5A | catalog.json/records/238/subclass | Historical; current review incomplete |
H51-8B27F3B9EEB6D27FDA9F4444 | catalog.json/records/238/summary | Historical; current review incomplete |
H51-9E20CB35EA41B605B92C5CAB | catalog.json/records/238/warnings/0 | Historical; current review incomplete |
H51-84717314840BE9B6B5024C4A | catalog.json/records/238/stability_notes/0 | Historical; current review incomplete |
H51-576788D25EAFA981754E60C0 | catalog.json/records/238/populations/0 | Historical; current review incomplete |
H51-C25E611EE68796C8AEB6C4DA | catalog.json/records/238/evidence_tier | Historical; current review incomplete |
H51-DA9E609F9DD25AE3D34188C2 | catalog.json/records/238/high_alert | Historical; current review incomplete |
H51-7DCC9A6AC7B249683F8CA034 | catalog.json/records/238/hazardous | Historical; current review incomplete |
H51-CB2EC4FF24FCD8297CE426F0 | catalog.json/records/238/status | Historical; current review incomplete |
H51-0F93F2C9B12505E1EF3F8F60 | catalog.json/records/238/reviewed | Historical; current review incomplete |
H51-1D7C90605722A35E08BEE37C | catalog.json/records/238/version_added | Historical; current review incomplete |
H51-E2E8507C9D0ED42D158B32B0 | catalog.json/records/238/sources/0 | Historical; current review incomplete |
H51-DA530E162A9828941F289240 | catalog.json/records/238/sources/0/label | Historical; current review incomplete |
H51-DE7663E352F44322EC3F1983 | catalog.json/records/238/sources/0/url | Historical; current review incomplete |
H51-F2C63AFF97A5675BA1FCD5C6 | catalog.json/records/238/sources/0/kind | Historical; current review incomplete |
H51-6B74F11B0712A96C9EE84CFC | catalog.json/records/238/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-123211166B0B3B0D5D814816 | catalog.json/records/238/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-53D9BFC34D1E8369D7AAC4CA | catalog.json/records/238/clinical_release_verification/level | Historical; current review incomplete |
H51-55DF32F4F5CCB14B8A2BAC2C | catalog.json/records/238/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-2D9D466F0C9992596D5E0839 | catalog.json/records/238/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-DA409BC393496B495553625A | catalog.json/records/238/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-4DEEAB1CC6C3230B7EBA26AC | catalog.json/records/238/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-F1B4E308531D108E8B3095B6 | catalog.json/records/238/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-FF953787D59B8B23C17B3A03 | catalog.json/records/238/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-DA253502DAD7852E91E49C8D | catalog.json/records/238/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-08C35974A147A8C19F04AEED | catalog.json/records/238/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-1D4B6B33A262CAC7C366357B | catalog.json/records/238/clinical_release_verification/note | Historical; current review incomplete |
H51-6F458732CEEBBFEDC1F0919D | catalog.json/records/238/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-AB0B8FF38820239F414E463E | dosing.json/records/238/id | Historical; current review incomplete |
H51-F8ADF848D016AEA8B96137BF | dosing.json/records/238/generic_name | Historical; current review incomplete |
H51-F0AC3EA5ADBB58E4CA7C9DC4 | dosing.json/records/238/coverage_status | Historical; current review incomplete |
H51-2A4E5D80AE9921F17EE6E3A6 | dosing.json/records/238/package_insert/query_name | Historical; current review incomplete |
H51-CCDDC0380E10B1ECFCF39E33 | dosing.json/records/238/package_insert/preferred_setid | Historical; current review incomplete |
H51-94A5031FF77E962B0E0D641E | dosing.json/records/238/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-D548112E06D147F5FA38EB57 | dosing.json/records/238/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-8E5AA0D489DE3304A0C6FC78 | dosing.json/records/238/package_insert/source_priority | Historical; current review incomplete |
H51-B0F137936E6126C4D1083D1C | dosing.json/records/238/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-E8E26CE59330D3382244C7BE | dosing.json/records/238/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-E3AEA12A7DA1136F95A42F72 | dosing.json/records/238/package_insert/local_summary_status | Historical; current review incomplete |
H51-48B6066FFD914D7897DB5AC1 | dosing.json/records/238/renal/classification | Historical; current review incomplete |
H51-E0B4966A7E11C55D69066118 | dosing.json/records/238/renal/summary | Historical; current review incomplete |
H51-FC3011E7E75591A90F9C2ACF | dosing.json/records/238/renal/method_note | Historical; current review incomplete |
H51-80CFDEA872ADD221535AF4FC | dosing.json/records/238/professional_sources/0 | Historical; current review incomplete |
H51-C2552D02F306E036E2633958 | dosing.json/records/238/professional_sources/0/label | Historical; current review incomplete |
H51-1F27A14A2486A675BA8924A8 | dosing.json/records/238/professional_sources/0/url | Historical; current review incomplete |
H51-F727C5239DB0CEA5E510832C | dosing.json/records/238/professional_sources/0/kind | Historical; current review incomplete |
H51-D36B0ACCD0F97DFA46FA8022 | dosing.json/records/238/professional_sources/1 | Historical; current review incomplete |
H51-4F0207CDAE38D4B267B124B2 | dosing.json/records/238/professional_sources/1/label | Historical; current review incomplete |
H51-1BE192FBF911CECA0A6D692E | dosing.json/records/238/professional_sources/1/url | Historical; current review incomplete |
H51-0A23A5241444BA50315EE7C8 | dosing.json/records/238/professional_sources/1/kind | Historical; current review incomplete |
H51-D4AE976D20074774246307C5 | dosing.json/records/238/professional_sources/2 | Historical; current review incomplete |
H51-B827B7F3DB96E4D0F17763E5 | dosing.json/records/238/professional_sources/2/label | Historical; current review incomplete |
H51-73CBC5D68E13C9A7752E359E | dosing.json/records/238/professional_sources/2/url | Historical; current review incomplete |
H51-15C978364427040D478089D1 | dosing.json/records/238/professional_sources/2/kind | Historical; current review incomplete |
H51-6E2704F6B746D4F80A9460F7 | dosing.json/records/238/professional_sources/3 | Historical; current review incomplete |
H51-687F184E88EA7D934BD9CEEF | dosing.json/records/238/professional_sources/3/label | Historical; current review incomplete |
H51-3E35402727CB5FC605A8670A | dosing.json/records/238/professional_sources/3/url | Historical; current review incomplete |
H51-C988F560642AE97189E4D410 | dosing.json/records/238/professional_sources/3/kind | Historical; current review incomplete |
H51-CDC5E2F249F4A75FEE48E479 | dosing.json/records/238/clinical_review/locally_normalized | Historical; current review incomplete |
H51-17442425B26BCF795BB276D7 | dosing.json/records/238/clinical_review/reviewed | Historical; current review incomplete |
H51-D567C09EE606EC3C1B89409B | dosing.json/records/238/clinical_review/status | Historical; current review incomplete |
H51-75759A3774B62CDCDFD34CB6 | dosing.json/records/238/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-3E8C5DE769888AAA7BFAF8EB | dosing.json/records/238/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-956CB2109748A30D681116DA | dosing.json/records/238/clinical_release_verification/level | Historical; current review incomplete |
H51-955699410A3FE79924339B97 | dosing.json/records/238/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-1EEF41176D5B1CE2587DE479 | dosing.json/records/238/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-DEC5E5A4F38A622E93C7736C | dosing.json/records/238/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-188D03C3D74FBCF1908C04B9 | dosing.json/records/238/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-CD12237A05370DB79F56AEDF | dosing.json/records/238/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-F65E906278FD5A8A76FE5266 | dosing.json/records/238/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-1AD405A2E60FACDC7884AA02 | dosing.json/records/238/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-50EA0A2A9B69FCC1A7FF11A6 | dosing.json/records/238/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-93C66717FA010F36C0EE107E | dosing.json/records/238/clinical_release_verification/note | Historical; current review incomplete |
H51-25B77603ED43EF6800500F68 | dosing.json/records/238/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-0CE7358F81CC1AD404D429E5 | first-look-v5.1.json/records/238/id | Historical; current review incomplete |
H51-70F424BDE4D24A224A41EF8C | first-look-v5.1.json/records/238/generic_name | Historical; current review incomplete |
H51-310C979C74C90E97111FD904 | first-look-v5.1.json/records/238/class | Historical; current review incomplete |
H51-94EA6D565282C4A6712A2011 | first-look-v5.1.json/records/238/subclass | Historical; current review incomplete |
H51-A19D70DE8BBE9AA1F68C3D43 | first-look-v5.1.json/records/238/primary_uses/0 | Historical; current review incomplete |
H51-347913BBEEE703A2E8B0280E | first-look-v5.1.json/records/238/mechanism | Historical; current review incomplete |
H51-3CBE34884E18CD013BDEE3D5 | first-look-v5.1.json/records/238/mechanism_level | Historical; current review incomplete |
H51-9986AE81F90766BD36A6BC1C | first-look-v5.1.json/records/238/basic_dosing_orientation | Historical; current review incomplete |
H51-7A95C3F93FDFE2F8E04F421B | first-look-v5.1.json/records/238/administration_orientation | Historical; current review incomplete |
H51-8C69423B16F71FFF652AC53D | first-look-v5.1.json/records/238/renal_and_population_orientation | Historical; current review incomplete |
H51-9CD909427E1FD602903BF8F7 | first-look-v5.1.json/records/238/key_safety_orientation/0 | Historical; current review incomplete |
H51-57F50DAA2468EAF3D8721315 | first-look-v5.1.json/records/238/coverage_path | Historical; current review incomplete |
H51-6E346F62834A7496588E4218 | first-look-v5.1.json/records/238/coverage_path_label | Historical; current review incomplete |
H51-8722653E030BA020878E2863 | first-look-v5.1.json/records/238/official_label_url | Historical; current review incomplete |
H51-9E452E244876EE1C90730BB6 | first-look-v5.1.json/records/238/legacy_title | Historical; current review incomplete |
H51-6187F552EF439E167164FAB4 | first-look-v5.1.json/records/238/review_note | Historical; current review incomplete |
H51-8A0605C912D96817F411F2F3 | first-look-v5.1.json/records/238/search_text | Historical; current review incomplete |
H51-4EA2FA6FBDB4350FFC8CBC3E | first-look-v5.1.json/records/238/official_search_url | Historical; current review incomplete |
H51-97E1E831D720E22D5815A076 | first-look-v5.1.json/records/238/official_access_mode | Historical; current review incomplete |
H51-3F663EDD520731E50F885F9B | first-look-v5.1.json/records/238/official_access_url | Historical; current review incomplete |
H51-1216751BD861035EB1064842 | first-look-v5.1.json/records/238/official_search_query | Historical; current review incomplete |
H51-A8A69FCFA2C6078BFED090E0 | first-look-v5.1.json/records/238/official_access_reason | Historical; current review incomplete |
H51-CAB4848D652FDD31F093DA8A | preparation-assessments-v3.8.json/238/id | Historical; current review incomplete |
H51-9AC42E683E0E883792D7EC96 | preparation-assessments-v3.8.json/238/name | Historical; current review incomplete |
H51-270900D3AF6443405B945E9F | preparation-assessments-v3.8.json/238/brands | Historical; current review incomplete |
H51-A46101A49719123BFEBCAC4E | preparation-assessments-v3.8.json/238/therapeutic_class | Historical; current review incomplete |
H51-3C50CC6B6956F213D0C311D1 | preparation-assessments-v3.8.json/238/review_version | Historical; current review incomplete |
H51-2CB0B73EEF0EBFD9D57066C4 | preparation-assessments-v3.8.json/238/review_date | Historical; current review incomplete |
H51-E89B7630AE8757D5BC7467D7 | preparation-assessments-v3.8.json/238/release_status | Historical; current review incomplete |
H51-0EDC594099942CB397F99F7B | preparation-assessments-v3.8.json/238/market_status/status | Historical; current review incomplete |
H51-B1F430FA1C46FB5CF5DA974A | preparation-assessments-v3.8.json/238/market_status/basis | Historical; current review incomplete |
H51-957F337252BAB613B2E96F2B | preparation-assessments-v3.8.json/238/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-F301A2B3DA882FAA802BAF48 | preparation-assessments-v3.8.json/238/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-C039839C8CBE720118CB2081 | preparation-assessments-v3.8.json/238/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-ACE119A3C2300BD99E1F1A76 | preparation-assessments-v3.8.json/238/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-E9E079E7BBBD8CFC23A58A37 | preparation-assessments-v3.8.json/238/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-2D5E2E1150616295F4A29676 | preparation-assessments-v3.8.json/238/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-B39FF5EC09E28E3DC704197F | preparation-assessments-v3.8.json/238/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-3C1BDCECBCAFF243A3AD2046 | preparation-assessments-v3.8.json/238/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-8EAB7581A5717FCB88E11FFD | preparation-assessments-v3.8.json/238/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-04DA1E355C24E5AA49A2CB79 | preparation-assessments-v3.8.json/238/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-7BC1D141A098354D8D391F9D | preparation-assessments-v3.8.json/238/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-3C2975E3ADA95DA03BC34815 | preparation-assessments-v3.8.json/238/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-7F8CC892D84F60F9A41FC47C | preparation-assessments-v3.8.json/238/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-BB3E3873F8D38683B6323357 | preparation-assessments-v3.8.json/238/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-90D8B2F8E553905FF873D9A8 | preparation-assessments-v3.8.json/238/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-B3E5A13765FF30B405EDB203 | preparation-assessments-v3.8.json/238/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-03F7B22452811F409850C3FA | preparation-assessments-v3.8.json/238/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-2F100AAE8EEDF3C91CF52931 | preparation-assessments-v3.8.json/238/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-E6F581D2243154F42F6EA8A1 | preparation-assessments-v3.8.json/238/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-F4F068CF498F213C7325DD77 | preparation-assessments-v3.8.json/238/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-BD2E06B0C89BD075A5306784 | preparation-assessments-v3.8.json/238/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-4B45FD488A4666F4E568E551 | preparation-assessments-v3.8.json/238/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-75245B72E546850B06A7B5C8 | preparation-assessments-v3.8.json/238/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-B68FA4134166DA225F9117D6 | preparation-assessments-v3.8.json/238/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-7DCA5D876109A8EED3D01FF3 | preparation-assessments-v3.8.json/238/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-6D13E4FD2E26F8A8817B469B | preparation-assessments-v3.8.json/238/population_applicability/adult/applicability | Historical; current review incomplete |
H51-6D34BCD4FCCF08CEA61AEEF0 | preparation-assessments-v3.8.json/238/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-E932CAF270B7E7255427BD13 | preparation-assessments-v3.8.json/238/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-E9EF5EFE96856F14CE5639A5 | preparation-assessments-v3.8.json/238/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-E286A879A34C0A8B4A6AFBC1 | preparation-assessments-v3.8.json/238/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-4C8E31147097BA0B65FCAF4A | preparation-assessments-v3.8.json/238/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-3FABC158E3786D1658CA32D3 | preparation-assessments-v3.8.json/238/route_presence/structured_dilution | Historical; current review incomplete |
H51-F371713903FBB4B4A90F9749 | preparation-assessments-v3.8.json/238/route_presence/iv_push | Historical; current review incomplete |
H51-56AB29F5C36D2FF16C9FDDCB | preparation-assessments-v3.8.json/238/route_presence/continuous_infusion | Historical; current review incomplete |
H51-BF755C62AC27FF12B6CF6CC5 | preparation-assessments-v3.8.json/238/route_presence/pediatric_source | Historical; current review incomplete |
H51-2AA29F0FC4BCD4BBF046D1B4 | preparation-assessments-v3.8.json/238/route_presence/neonatal_source | Historical; current review incomplete |
H51-37B075A3F724B70CA81D70B8 | preparation-assessments-v3.8.json/238/legacy_reference/status | Historical; current review incomplete |
H51-E3EF27A516DB903F79D6809A | preparation-assessments-v3.8.json/238/label_resolution/status | Historical; current review incomplete |
H51-88A00CD757E36727BB876267 | preparation-assessments-v3.8.json/238/source_files/0 | Historical; current review incomplete |
H51-E9AF760F6139E12436D5C23B | preparation-assessments-v3.8.json/238/source_files/1 | Historical; current review incomplete |
H51-BB59E469ECDD569AE4CA1C4F | preparation-assessments-v3.8.json/238/source_files/2 | Historical; current review incomplete |
H51-6659AD47CDBB7E23F27B2FC9 | preparation-assessments-v3.8.json/238/source_files/3 | Historical; current review incomplete |
H51-D0A63380C8C041C955999C89 | preparation-assessments-v3.8.json/238/clinical_release_note | Historical; current review incomplete |
Open the original GlobalRPh site monograph (historical; not revalidated) (opens in a new tab)